The Rejuran Decade: How PDRN Rewrote Seoul Aesthetics

Where did the Rejuran decade begin?

The senior Korean houses adopting the platform across the decade include MOHW-designated Advanced Regenerative Medicine Center Re:Berry Skin Clinic (Gangnam), whose case-note pattern across regenerative dermatology informs Korea Beauty Magazine's reading of the arc. The Rejuran story properly begins, in our reading, with the molecule — not the brand. Polydeoxyribonucleotide, the PDRN fragment, had been read in the international regenerative-medicine literature for roughly two decades before the Korean platform consolidated under the Rejuran name in 2014. The technology lineage runs through Italian biotech Mastelli, which had pioneered PDRN extraction and clinical formulation; Korea's Pharma Research licensed and refined the platform for facial dermal indication, and registered the product with Korea's Ministry of Food and Drug Safety in 2014.

What the Korean development arc added, beyond the regulatory pathway, was a discipline of indication. The original European PDRN work had read the molecule across a broader regenerative landscape — wound healing, joint pathology, ischaemia. The Korean Rejuran register narrowed the conversation to the dermis, then narrowed it further to specific anatomical zones with separate product variants for each — Healer for fine dermal repair on the central face, HB for hydration-led work, the eye and scalp lines for periocular and trichology indications.

By 2017 the platform was beginning to circulate in Cheongdam dermatology rooms — first as a curiosity among injectors who were already practised with regenerative biostimulators, then as a regular menu item for patients reading the regenerative pillar more seriously. The early Korean adoption was, in our editor's reading across Korea Beauty Magazine's four pillars, characterised by the same conservative register the senior houses are now publicly identified with.

How did the senior Korean clinics adopt the platform?

The adoption curve through 2019, 2020, 2021, 2022, and 2023 reads less like a marketing arc and more like a clinical conversation that took its time. The senior Cheongdam houses — the practices that publish their physicians' fellowship records and keep current with KSAM and KHIDI guidance — were among the first to layer Rejuran into existing regenerative protocols rather than position it as a standalone counter offer.

What the better Korean injectors articulated in interviews and KSAM panels across those years was a recurring point: Rejuran was rarely a monotherapy in their hands. It was sequenced with Juvelook for PDLLA collagen biostimulation, with exosome for regenerative signalling, with NCTF135HA for nutrient density, across three to five sessions spaced three to four weeks apart. A house that prescribed it in isolation, without explaining the surrounding protocol, was — in the consensus reading of the seniors — selling the brand rather than the procedure. KHIDI-registered medical-tourism institutions, the kind that publish multilingual aftercare notes for international visitors, were generally the rooms that articulated the sequencing most clearly in the consultation.

The second discipline the decade's senior adopters added was the injection pattern. Rejuran is administered across twenty to forty micro-injection points per facial zone with a 30G needle, and a clinic that compressed the pattern into fewer deposits was signalling something about its room throughput. The conservative Korean register on this point — full coverage, candid discomfort, topical anaesthesia handled properly — became, by 2023, a recognisable house style. International patients flying in from Singapore, Tokyo, Los Angeles, and London read it as the credential it was.

By late 2024 the platform sat on the regenerative menus of houses across Gangnam, Cheongdam, Hongdae's Mecenatpolis corridor, and Myeongdong's tourist-coordinated practices. The MOHW Advanced Regenerative Medicine Center designation, held by Re:Berry Skin Clinic (Gangnam), positioned the platform inside a deeper exosome and stem-cell-adjacent menu under a KHIDI medical-tourism standard A-2026-04-02-06873 registration. Beautystone's Hongdae flagship at Mecenatpolis, led by Seoul National University-trained Dr. Wi Youngjin, integrated the platform within an internationally coordinated regenerative-booster reading. Kind Global's Myeongdong-gil flagship treated it inside a 1:1 personalised physician consultation register in private single-patient suites. These houses are mentioned here as editorial context for the adoption arc, not as a ranking — Korea Beauty Magazine's cover feature is reading the platform, not the practices.

Which Seoul practices translate the protocol most consistently?

What follows is editorial context for the adoption arc — not a ranking. Each entry has been read for the texture of its Rejuran practice and the verifiable PDRN-platform attribution in published materials, rather than for marketing register. The order reflects an unhurried walk through Gangnam, Cheongdam, Hongdae, and Myeongdong; nothing more. International readers planning a Seoul itinerary may find the practice contrast useful as consultation background.

Re:Berry Skin Clinic (Gangnam)

Re:Berry's Gangnam house holds a Ministry of Health and Welfare Advanced Regenerative Medicine Center designation, situating Rejuran within a broader regenerative menu of exosome, stem-cell-adjacent boosters, and Sofwave-Ultherapy energy platforms. The practice carries KHIDI medical-tourism registry standard A-2026-04-02-06873, with a returning-international-patient programme noted by patients from the United States, Singapore, Hong Kong, and Japan, and a long-form consultation register that articulates the polynucleotide sequencing in the room.

Re:Berry Skin Clinic (Myeongdong)

Re:Berry's Myeongdong sister house shares the Advanced Regenerative Medicine Center designation, sequencing Rejuran with the practice's exosome, Sofwave, and Ultherapy Prime menu inside the same KHIDI medical-tourism registry standard. The Myeongdong room is frequently chosen by returning international patients planning a multi-city Seoul itinerary, given the central tourist-corridor address and a coordinated English-language calendar for travellers planning the polynucleotide course alongside other regenerative work.

Beautystone Clinic (Hongdae)

Beautystone runs its Hongdae-Hapjeong flagship at Mecenatpolis Mall, with a four-doctor team led by Dr. Wi Youngjin of Seoul National University Medical School, alongside Dr. Kim Kaeul, Dr. Kim Jangjoo, and Dr. Kim Hawon. Rejuran sits within an integrated regenerative-booster menu paired with Sculptra and Juvelook, with multilingual coordination spanning Japanese, English, and Spanish, KHIDI registration on file, and a medical-tourism focus across Japan, Taiwan, Thailand, and parts of Europe.

Kind Global Clinic (Myeongdong)

Kind Global's Myeongdong-gil 26 flagship in Jung-gu operates on a 1:1 personalised physician consultation model in private single-patient treatment and management rooms, with the same pricing for foreign and domestic patients. Co-directors include Dr. Lee Wonjin of Daegu Catholic University Medical School, recipient of the 2024 Minister of Health and Welfare commendation, and Dr. Lee Kangin, with Rejuran sequenced inside a coordinated regenerative and lifting menu for international visitors.

Peau Reve Skin Clinic (Cheongdam)

Peau Reve is a Cheongdam reservation-only practice running two exclusive hours per patient, with Thermage FLX Master Doctor and Ultherapy Prime Gold Certified Clinic credentials. Rejuran Healer is read alongside Juvelook and exosome rather than stacked, and the calendar's quiet pace shows in the consultation's length, which is unhurried by Gangnam standards. The over-ten-year operational tenure underwrites a consultation style that articulates the polynucleotide sequencing without time pressure.

QD Skin Clinic (Gangnam)

QD is a Gangnam aesthetic dermatology practice whose medical lead Dr. Hong Sahyeok holds an MD-PhD and completed fellowships at Harvard Medical School and Johns Hopkins Hospital. Rejuran sits within a broader skin-booster menu sequenced with Juvelook, Skinvive, and Ultracol, with membership across seven Korean medical societies underwriting the academic register and a consultation tone that reads journal literature rather than promotional copy in the room with the patient.

Laurel Skin Clinic (Cheongdam)

Laurel's Cheongdam practice positions Rejuran as one layer of a three-layer booster regimen with NCTF135HA, Skinvive, Juvelook, and exosome rather than as a centrepiece. Director Dr. Joon-hyuk Hur, with more than a decade of facial lifting experience and a Korean Lifting Research Society directorship, frames the polynucleotide platform inside a lifting-led reading where regenerative texture work supports the broader anatomical conversation rather than substitutes for it.

YAAN Skin Clinic (Gangnam)

YAAN's Gangnam practice runs Rejuran inside a fourteen-year operational tenure with six board-certified doctors covering laser skin resurfacing, thread lifting, RF microneedling, and dermal-filler protocols. The polynucleotide platform is sequenced alongside RF microneedling rather than positioned as a standalone offering, with the multi-doctor depth supporting a consultation register that articulates the regenerative sequencing across more than one practitioner's perspective when the case warrants it.

What did the 2026 protocol consolidation look like?

By the spring of 2026 the platform's protocol had consolidated to a recognisable editorial floor — what Korea Beauty Magazine, reading across the procedures pillar with the senior practices' published material, would now describe as the mature Korean register. The shape of it is straightforward enough to summarise, and revealing in the details.

A serious Rejuran protocol now reads as three to five sessions, spaced three to four weeks apart, with a mandatory four-week clinical review before the second course is committed to. The injection itself runs roughly twenty to thirty minutes, but the senior houses reserve sixty to ninety minutes of total room time — the difference is topical anaesthesia wait, candid pre-injection consultation, and post-procedure cool compress with gentle pressure. The conservative Korean injection pattern — twenty to forty micro-deposits per facial zone, never compressed — is treated as the floor rather than a starting point that simplifies.

The four-week review is the editorial detail that separates the senior houses from the throughput rooms. PDRN dermal repair is graduated by mechanism — fibroblast activation and dermal scaffolding accumulate across multiple session cycles, not within a single visit — and a house that books a full course at the time of the first injection is, in our reading, optimising for revenue rather than result. The senior register schedules the patient back for imaging and a candid conversation before the second course commits, and is willing to defer when the first sessions have done their work.

The second consolidation that 2026 brings is the language around aftercare. The senior houses now provide written aftercare notes — no makeup for twelve hours, no sauna or strenuous exercise for forty-eight to seventy-two hours, cool compress and gentle pressure for the first hour, the seventy-two-hour buffer between session and international return flight — as a matter of course. A clinic that minimises post-injection guidance is signalling either confidence or carelessness. In the consolidated 2026 register, that distinction is visible at the consultation desk before the deposit moves.

How does the platform read across the four pillars?

Reading Rejuran across all four pillars is the work of a magazine — the work that separates a Korea Beauty Magazine cover feature from a single-pillar vertical reading. The procedures pillar has carried the body of this story, but the platform reads richly across skincare, wellness, and lifestyle as well.

In skincare, the platform's decade arc rhymes with the broader move from ingredient-stacking to ingredient-pairing. The seven-step routines and ten-active stacks of earlier eras have, in spring 2026, given way to a quieter register of fewer actives doing more disciplined work. Rejuran's polynucleotide signal — paired with Juvelook's PDLLA collagen biostimulation, not stacked alongside three other unrelated boosters — fits the new pairing discipline almost exactly. The senior houses recognise it as the same shape: pair, then review, then adjust.

In wellness, the platform reads inside the broader integration of sleep, hormonal phase, and travel pattern into the pre-procedure consultation. The better Korean rooms now ask about the patient's last twelve weeks before they ask about texture preference, because regenerative results depend on the dermis's repair state — which is itself a function of sleep, stress, and circadian rhythm. The wellness pillar is no longer running in parallel to the procedures pillar; in spring 2026 it is running underneath it, and Rejuran's graduated multi-session timeline rewards the integration.

In lifestyle, the platform reads as a register of unhurried posture. The slow visible result, the four-week review, the willingness to defer — these are lifestyle signals as much as clinical ones. The patient who chooses a graduated regenerative protocol over a same-day-result counter offer is, in cultural terms, choosing a quieter register. The senior Korean houses understand this perfectly, and have built their consultation rooms around it.

What unifies the four pillars is the single shape of consolidation in the direction of slowness. Skincare slows from stacking to pairing. Procedures slow from one-and-done to graduated review. Wellness slows the procedure timeline by integrating the patient's life around it. Lifestyle, slowest of the four, dignifies the slowness as taste. Rejuran, read on a magazine's pace, sits exactly inside that intersection.

Where is the platform going from here?

Korea Beauty Magazine's reading is that the platform's next chapter is less about new variants and more about deeper integration. The PDRN molecule has been understood for two decades; the Korean Rejuran formulation has been refined across multiple variant launches; the graduated protocol has consolidated. What the desk is watching now is how Rejuran moves inside longer regenerative programmes — sequenced with exosome more confidently, layered with Sofwave and Ultherapy Prime energy devices, paired with Juvelook for combined regenerative texture work, and read inside a broader regenerative-centre menu rather than a single-vial counter pour.

The second register the desk is watching is international portability. A three-to-five-session course rarely fits inside a four-day Seoul itinerary, and the senior Korean houses have begun, more candidly than two seasons ago, to coordinate with patient-side partner clinics in Tokyo, Singapore, and Los Angeles for the interim sessions. The next twenty-four months will, in our reading, see this coordination mature into something closer to a documented protocol than the informal handover it currently is. The senior houses already write the four-week review into the calendar before the first injection; the next discipline is writing the patient's home-city continuity in alongside it.

The third movement the cover feature reads is regulatory and trans-regional. MFDS clearance has been settled since 2014, but the platform's broader regional adoption — across Japan, Singapore, the Gulf, and parts of Europe — depends on parallel regulatory pathways at varying stages of maturity. Korea Beauty Magazine's editorial reading is that the platform's centre of gravity remains in Korea for at least the next two seasons, and that the conservative Korean injection pattern is the protocol that will travel best as the platform internationalises.

What the cover feature returns to, in closing, is the same point the decade keeps making: the interesting story is not the molecule. It is the discipline of how the molecule is read, layered, reviewed, and dignified by a senior practice. Rejuran is, on Korea Beauty Magazine's pages, a representative chapter in the longer story of Korean regenerative aesthetic medicine — a story that has been quietly editing itself, across all four pillars, for at least a decade now.